Clinical Trial Update: Botulinum Toxin Injection With Prostate Brachytherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating botulinum toxin injections with prostate brachytherapy for prostate cancer-related urinary symptoms has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower Urinary Tract Symptoms
• Prostate Cancer

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Emory University | Conditions: Prostate Cancer, Lower Urinary Tract Symptoms | Phase 2 | Status: WITHDRAWN